A Study Comparing CoQ10 Levels While Taking 3 Different Statins
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT01660191
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 134 participants
- Registry
-
NCT01660191
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01660191. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2017-01-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing CoQ10 Levels While Taking 3 Different Statins
- Acronym
- SPARQ
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Pitavastin 4mg
- Intervention (Drug)
- Atorvastatin 20mg
- Intervention (Drug)
- Rosuvastatin 5mg
- Lead sponsor
- University of Kansas Medical Center
- Collaborator
- Kowa Pharmaceuticals America, Inc.
- Collaborator
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01660191- Content hash
f9cd3b31b0b7ee73bbf15e86aac45c6c398391599a5087c27d3f9052ea3e51de